Committed with the
MOEHS quality policy is based on GMP standards for manufacturers of Active Pharmaceutical Ingredients (CFR 210-211 and ICHQ7).
Likewise, our manufacturing plants are regularly inspected and accredited by the main world drug agencies such as PMDA, FDA, Russian Authorities, K-FDA (Korea), TGA (Australia).
Combine the requirements of the GPM standards with the demands of our clients in a single organization of quality that collects all the needs to provide an efficient system and the continuous improvement of our service.
MOEHS IS COMMITTED TO THE QUALITY POLICY
AND ITS MAINTENANCE. TO ACHIEVE THIS OBJECTIVE IT IS ORGANIZED
IN 4 LARGE AREAS: